Corrigendum to ‘The CAP-CR study: Direct medical costs in Italian metastatic colorectal cancer patients on first-line infusional 5-fluorouracil or oral capecitabine’ [European Journal of Cancer 44 (2008) 2615–2622]
2008 ◽
Vol 44
(17)
◽
pp. 2615-2622
◽
2009 ◽
pp. 285-293